CRISPR/Cas9 technology generated a 908 bp deletion that eliminated exon 44, producing a premature stop codon in exon 45. This is one of the most common deletions responsible for Duchenne muscular dystrophy in humans. RT-PCR and product sequencing confirmed the deletion of exon 44. Western blot analysis confirmed the absence of protein. (J:285447)